Effects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats
Jazyk angličtina Země Španělsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- časové faktory MeSH
- kathepsin B chemie MeSH
- kathepsin L chemie MeSH
- kosterní svaly účinky léků metabolismus MeSH
- krysa rodu Rattus MeSH
- kyslík chemie MeSH
- leucin chemie MeSH
- lyzozomy metabolismus MeSH
- potkani Wistar MeSH
- proteasomový endopeptidasový komplex chemie MeSH
- sepse farmakoterapie metabolismus MeSH
- valeráty farmakologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- beta-hydroxyisovaleric acid MeSH Prohlížeč
- kathepsin B MeSH
- kathepsin L MeSH
- kyslík MeSH
- leucin MeSH
- proteasomový endopeptidasový komplex MeSH
- valeráty MeSH
β-Hydroxy-β-methylbutyrate (HMB) is a leucine metabolite that may have a positive effect in protein catabolic conditions. Therefore, we hypothesized that HMB treatment could attenuate the sepsis-induced protein catabolic state. The aims of our study were to elucidate the effect of HMB in healthy and septic animals and to evaluate the differences in the action of HMB in different muscle types. Intact and septic (5 mg endotoxin/kg i.p.) rats were administered with HMB (0.5 g/kg/day) or saline. After 24 h, extensor digitorum longus (EDL) and soleus (SOL) muscles were isolated and used for determination of total and myofibrillar proteolysis, protein synthesis, leucine oxidation, activity of cathepsins B and L, chymotrypsin-like activity, and expression of α-subunits of proteasome. Our results indicate that the catabolic state induced by the endotoxin treatment was caused both by increase in protein breakdown (due to activation of proteasome system) and by attenuation of protein synthesis. The EDL (muscle composed of white, fast-twitch fibers) was more susceptible to these changes than the SOL (muscle composed of red, slow-twitch fibers). The HMB treatment had no effect in healthy animals but counteracted the changes in septic animals. The action of HMB was mediated by attenuation of proteasome activity and protein breakdown, not by stimulation of protein synthesis. More pronounced effect of the HMB treatment on myofibrillar proteolysis was observed in the SOL.
Zobrazit více v PubMed
Cancer Res. 2004 Dec 1;64(23):8731-5 PubMed
J Chromatogr B Biomed Sci Appl. 1997 Aug 15;696(1):1-8 PubMed
Endocrinology. 2005 Jul;146(7):3141-9 PubMed
Metabolism. 1986 Dec;35(12):1121-7 PubMed
Intensive Care Med. 2002 Feb;28(2):108-21 PubMed
JPEN J Parenter Enteral Nutr. 2000 May-Jun;24(3):133-9 PubMed
Int J Biochem Cell Biol. 2005 Oct;37(10):2196-206 PubMed
World J Surg. 1998 Feb;22(2):203-8 PubMed
Biochem Biophys Res Commun. 2000 Apr 2;270(1):215-21 PubMed
J Anim Sci. 1990 Aug;68(8):2362-70 PubMed
J Biol Chem. 1975 Jan 10;250(1):290-8 PubMed
J Appl Physiol (1985). 2003 Feb;94(2):651-9 PubMed
Clin Nutr. 2005 Jun;24(3):442-54 PubMed
Biochem J. 1991 Jun 1;276 ( Pt 2):405-9 PubMed
Am J Surg. 2002 Apr;183(4):471-9 PubMed
Cancer Res. 2005 Jan 1;65(1):277-83 PubMed
Int J Exp Pathol. 2008 Feb;89(1):64-71 PubMed
Am J Physiol. 1997 Dec;273(6):E1052-8 PubMed
Biochem J. 1977 Mar 15;162(3):557-68 PubMed
Nutr Res. 2008 Jul;28(7):487-93 PubMed
Clin Nutr. 2003 Oct;22(5):437-43 PubMed
Thorax. 2004 Sep;59(9):808-17 PubMed
Ann Nutr Metab. 2006;50(4):361-7 PubMed
Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1417-26 PubMed
Am J Physiol Endocrinol Metab. 2007 Oct;293(4):E923-31 PubMed
J Biol Chem. 2004 Dec 17;279(51):52914-23 PubMed
J Hepatol. 2006 Mar;44(3):576-85 PubMed
Biochem J. 1995 May 1;307 ( Pt 3):639-45 PubMed
Cancer Lett. 2002 Jun 6;180(1):69-74 PubMed
Biochem J. 2007 Oct 1;407(1):113-20 PubMed
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):222-6 PubMed
Food Chem Toxicol. 2009 Jan;47(1):255-9 PubMed
Pediatr Nephrol. 2008 Apr;23(4):527-35 PubMed
Am J Physiol. 1997 Mar;272(3 Pt 2):R849-56 PubMed
Anal Biochem. 1980 May 15;104(2):284-9 PubMed
Cell Metab. 2007 Nov;6(5):376-85 PubMed
Am J Physiol. 1999 Aug;277(2):R434-40 PubMed
Anal Biochem. 1993 Jun;211(2):279-87 PubMed
J Biol Chem. 1951 Nov;193(1):265-75 PubMed
Burns. 2002 Sep;28(6):527-33 PubMed
J Biol Chem. 1973 Oct 25;248(20):7272-5 PubMed
The Role of Inflammation in Age-Related Sarcopenia
The dose-dependent effects of endotoxin on protein metabolism in two types of rat skeletal muscle
Muscle wasting in animal models of severe illness